Results 11 to 20 of about 1,994,828 (407)

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most ...
R. Haddad, Lindsay A. Bischoff, D. Ball, V. Bernet, E. Blomain, N. Busaidy, Michael Campbell, P. Dickson, Q. Duh, H. Ehya, W. Goldner, Theresa W Guo, M. Haymart, Shelby Holt, J. Hunt, A. Iagaru, F. Kandeel, D. Lamonica, S. Mandel, S. Markovina, B. Mciver, C. Raeburn, R. Rezaee, J. Ridge, M. Roth, R. Scheri, J. Shah, J. Sipos, R. Sippel, C. Sturgeon, Thomas Wang, L. Wirth, R. Wong, Michael W Yeh, Carly J Cassara, S. Darlow   +35 more
semanticscholar   +1 more source

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Thyroid, 2021
Background: Anaplastic thyroid carcinoma (ATC) and metastatic poorly differentiated thyroid carcinomas (PDTCs) are rare aggressive malignancies with poor overall survival (OS) despite extensive multimodal therapy.
C. Dierks, J. Seufert, K. Aumann, J. Ruf, Claudius Klein, S. Kiefer, Michael Rassner, M. Boerries, A. Zielke, P. La Rosée, P. Meyer, M. Kroiss, C. Weissenberger, T. Schumacher, Patrick Metzger, H. Weiss, C. Smaxwil, K. Laubner, J. Duyster, N. von Bubnoff, C. Miething, O. Thomusch   +21 more
semanticscholar   +1 more source

The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

medRxiv, 2023
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown.
P. Zeng, S. Prokopec, Stephen Y Lai, N. Pinto, M. Chan-Seng-Yue, R. Clifton-Bligh, Michelle D. Williams, Christopher J. Howlett, P. Plantinga, Matthew J. Cecchini, Alfred K. Lam, Iram Siddiqui, Jianxin Wang, Ren X. Sun, John D. Watson, R. Korah, T. Carling, Nishant Agrawal, N. Cipriani, D. Ball, B. Nelkin, L. Rooper, J. Bishop, C. Garnis, Ken Berean, Norman G. Nicolson, Paula M. Weinberger, Y. Henderson, Christopher M. Lalansingh, Mao Tian, Takafumi N. Yamaguchi, J. Livingstone, A. Salcedo, Krupal B. Patel, F. Vizeacoumar, A. Datti, Liu Xi, Y. Nikiforov, R. Smallridge, J. Copland, L. Marlow, Martin Hyrcza, L. Delbridge, S. Sidhu, M. Sywak, Bruce G. Robinson, K. Fung, F. Ghasemi, K. Kwan, S. D. MacNeil, A. Mendez, David Palma, Mohammed I. Khan, M. Shaikh, Kara M. Ruicci, B. Wehrli, E. Winquist, J. Yoo, J. Mymryk, J. Rocco, David A. Wheeler, Steve W. Scherer, T. Giordano, J. Barrett, W. Faquin, A. Gill, G. Clayman, P. Boutros, A. Nichols, Tomassina Spina, Piero Bill George, Maria Manzini, Rina Deroo, Shani Loewith, Carol Castellucci, Bill Van Haeren, Jennifer Stevanovich, Pat Baird, Jeff Nichols, Linda Zaluski, Thomas Vandertuin, Paul Green   +81 more
semanticscholar   +1 more source

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma

European Thyroid Journal, 2022
At present, no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize the ...

semanticscholar   +1 more source

Anaplastic Thyroid Carcinoma: An Update

Cancers, 2022
Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic. Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected cases with actionable genomic alterations or with favorable immune tumor microenvironment,
Arnaud Jannin, A. Escande, A. Al Ghuzlan, P. Blanchard, D. Hartl, B. Chevalier, F. Deschamps, L. Lamartina, L. Lacroix, C. Dupuy, E. Baudin, C. Do Cao, J. Hadoux   +12 more
semanticscholar   +1 more source

Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy

Frontiers in Oncology, 2023
IntroductionDifferentiated thyroid carcinoma (DTC) in childhood and during adolescence is extremely rare. Pediatric DTC commonly presents with advanced disease at diagnosis including a high prevalence of cervical lymph node metastases and pulmonary ...
Caroline Burgard, Caroline Burgard, Mathias Johannes Zacherl, Mathias Johannes Zacherl, Andrei Todica, Andrei Todica, Julia Hornung, Freba Grawe, Freba Grawe, Isabell Pekrul, Petra Zimmermann, Petra Zimmermann, Christine Schmid-Tannwald, Christine Schmid-Tannwald, Roland Ladurner, Detlef Krenz, Arnold Trupka, Johanna Wagner, Peter Bartenstein, Christine Spitzweg, Christine Spitzweg, Vera Wenter   +21 more
doaj   +1 more source

Anaplastic Thyroid Carcinoma [PDF]

Frontiers in Endocrinology, 2012
Thyroid cancers represent about 1% of all human cancers. Differentiate thyroid carcinomas (DTCs), papillary and follicular cancers, are the most frequent forms, instead Anaplastic Thyroid Carcinoma (ATC) is estimated to comprise 1-2% of thyroid malignancies and it accounts for 14-39% of thyroid cancer deaths. The annual incidence of ATC is about one to
Taccaliti, Augusto, Silvetti, Francesca, Palmonella, Gioia, BOSCARO, MARCO   +3 more
openaire   +4 more sources

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases

Thyroid, 2020
Background: Anaplastic thyroid carcinoma (ATC) is nearly always fatal. Large studies on ATC are exceedingly rare. We aimed to study the clinical, genotypic, and histologic characteristics of ATC in the largest retrospective cohort of ATC to date. Methods:
Bin Xu, T. Fuchs, S. Dogan, Iňigo Landa, N. Katabi, J. Fagin, R. Tuttle, E. Sherman, A. Gill, R. Ghossein   +9 more
semanticscholar   +1 more source

Medullary thyroid carcinoma [PDF]

Clinical Endocrinology, 2004
SummaryMedullary thyroid carcinoma (MTC) arises from parafollicular or C cells that produce calcitonin (CT), and accounts for 5–10% of all thyroid cancers. MTC is hereditary in about 25% of cases. The discovery of a MTC in a patient has several implications: disease extent should be evaluated, phaeochromocytoma and hyperparathyroidism should be ...
Sophie, Leboulleux, Eric, Baudin, Jean-Paul, Travagli, Martin, Schlumberger   +3 more
  +7 more sources

Histopathological study of thyroid carcinoma in Misan province [PDF]

Journal of Bioscience and Applied Research, 2022
Aims: "Thyroid carcinoma is specific malignant tumors derived from follicle cells including papillary and follicular carcinoma, and parafollicular, calcitonin-producing C-cells (medullary carcinoma)".This study aimed to provide a present outlook on ...
Osamah Wali, Abbas Mraisel, Alaa Salih
doaj   +1 more source